Biopharma Commercial Strategy Consultants Merging the Worlds of Biopharma & Technology
Founder & CEO
Letter from Our Founder
It has often been said that life experience shapes who you are and where you focus your passions. When we first developed Corval® in 2020, we introduced a disruptive digital solution to enable early-to-mid-stage biopharma companies to develop a commercialization roadmap, budget, and hiring plan in record time. Our deep industry and tech experience helped us create a tool that delivered what we said it would provide.
Since then, there has been a dramatic shift in how work is done post-pandemic, the constraints on the biopharma ecosystem due to inflation and higher cost of capital, and the significant, but not yet understood, implications of introducing AI.
The benefit of life experience has allowed us to learn from team members, our customers who utilized the platform, and numerous experts who provided feedback.
What continues to drive us:
- Integrated commercialization planning remains critical for companies to deliver on their vision of serving patients. Many obstacles exist on the path from the clinic to the market, and it is essential to recognize and address them.
- Biopharma has high technology aspirations, but technology adoption remains challenging and slow. Adaptable human support and expertise are part of the total solution.
- Multiple stakeholders influence and impact the multi-year, multi-dimensional commercialization plan and need a reliable platform to house the single source of truth. Many stakeholders don’t know the full extent of what is required to bring a drug from development through launch and benefit from a trusted guide.
Life experiences have continued to focus our passions on delivering an evolving, innovative solution during these changing times. We are customer-focused and continuously monitor industry and customer trends.
What we commit to deliver:
- Corval is a disruptive solution built by biopharma industry experts who understand what is needed now and how often the planning horizon changes. Interdependencies and ease of updates are essential.
- By responding to the “voice of the customer” and re-architecting the platform, Corval creates a fully integrated commercialization solution that extends through launch and provides the customer complete control.
- Corval benefits emerging biopharma companies and the service providers that support them in the journey to market from Phase 1 through launch with a multi-year, multi-dimensional solution designed specifically for them.
I am grateful to the many team members, advisors, and experts who have shared their talents, insights, and ideas with us so that we can continue to evolve.
I am also grateful to all the customers who trusted us in the early years and excited to serve them and future customers with the newly enhanced Corval solution!
OUR MISSION
Deliver an end-to-end ecosystem that guides biopharma companies through the commercialization process by leveraging decades of strategic commercialization expertise with innovative technology and expert consulting services to deliver a lower-cost, higher-value, single-source solution for long-term success.
Meet Our Biopharma Commercial Strategy Consultants
We’re a team with big ideas committed to changing the way that innovative therapies get to patients. And we’re growing every day.
Susan Nemetz
Founder
& CEO
Susan is a proven leader and successful entrepreneur in the life science industry. In addition to founding and leading Corval, a novel SaaS platform company, she is the CEO and Founder of The NemetzGroup, a successful, strategic commercialization consultancy. The NemetzGroup has been instrumental in supporting the evolution of over 100 biopharma companies from startup to publicly traded and the development of numerous assets from targets to approved, life-saving treatments. With more than 35 years of corporate strategy, commercial, medical affairs, business development, and operational experience, C-suite leadership teams rely on her thought partnership and mentoring to achieve goals across all stages of drug development.
Prior to launching The NemetzGroup in 2003, Susan served as Vice President, Global Commercial Strategy, and then Vice President of International Commercial Operations at Millennium Pharmaceuticals. Previously, she progressed through multiple commercial leadership roles at DuPont Pharmaceuticals that culminated in her appointment as Executive Vice President of the cardiovascular and imaging franchise. Susan serves as an advisor of Life Science Cares, a collective effort of the life science industry to eliminate the impact of poverty on Boston neighborhoods. Susan received her BS in business management from the University of Minnesota.
Mairelisa Alcantara
Business Analyst &
Implementation Specialist
Mairelisa serves as Corval’s Business Analyst, where she coordinates across product and content workflows to support data management, quality analysis, and ongoing product upgrades. Prior to joining Corval, Mairelisa worked for the US Census Bureau, the Mayor's Office of Workforce Development, and the Grand Circle Corporation, where she held a range of responsibilities and gained technical skills in database management, project management, and product and software development. Currently pursuing a BA in Economics at UMass Amherst, Mairelisa enthusiastically continues to support the Corval vision.
Jeff Alexander
head of product
Theodora Bibila
commercialization
Strategy Lead
Dora joined Corval in 2022 and is our Commercialization Strategy Lead. She is an innovative senior Pharmaceutical/Biotech Executive with deep experience and demonstrated success in leading strategy, product development, and global commercialization with a passion for making a positive impact on patients’ lives and global health.
Most recently, Dora led the cross-functional team responsible for product development and commercialization for the Alzheimer’s Disease product portfolio at Biogen. She directly managed the global commercial team responsible for the development of the strategy and all preparations for the global launch of Aducanumab. Prior to joining Biogen, she was with Merck in roles of increasing responsibility in R&D and marketing at the country, regional, and global level, and has extensive launch experience including several blockbuster brands. She has been instrumental in leading successful strategic partnerships and large public- and private-sector customer contracting and pricing negotiations.
She holds a BS in Chemical Engineering from the Aristotle University of Thessaloniki, Greece, an MS and PhD in Biochemical Engineering from the University of Minnesota, and an MBA from Rutgers Graduate School of Business.
Melinda Fayette
Director of
Marketing
Melinda joins Corval as Director of Marketing, where she is responsible for the strategy, development, and execution of marketing, brand, and messaging efforts. She has a proven track record of success in building top-flight systems from the ground-up for start-ups and medium- to enterprise-level organizations specializing in biotech and life sciences. Most recently, Melinda led marketing communications at Cold Chain Technologies, where she executed the successful pivot to provide specialized packaging solutions in response to the COVID-19 pandemic and the CDC’s Operation Warp Speed. Preceding that, she led digital marketing and social media efforts for a variety of life science and consumer product companies. Melinda has a BFA in Graphic Design from the University of Connecticut, School of Fine Arts.
Leon Huggins
software engineer
Leon Huggins is a Software Developer at Corval, where he collaborates with the product team to deliver code that directly affects what the clients see and interact with. Leon's hobbies include graphic design as well as music production and engineering which translate into creative ideas when brainstorming with the product team on future features. Prior to working at Corval, Leon worked in Fintech at Northwestern Mutual as a Frontend developer, after attending Flatiron School where he studied software engineering.
Chris Katsaros
Senior Developer
Chris Katsaros joined Corval in 2024 as a Senior Developer with expertise in software ideation, sales, development, and integration. He is a tech enthusiast with a strong curiosity for the latest trends in software and is highly skilled in both front-end and back-end development for B2B and B2C software features. Chris has a proven track record of working directly with internal and external customers, consistently exceling in translating business needs into scalable software solutions and delivering automation and data insights with measurable success.
In his recent role as a Senior Software Architect at Johnson & Johnson Insurance Agency, Chris created and utilized AI models to estimate profitability, optimized database efficiency, and led the development of a new one-step quoting insurance system.
Born in the Midwest, Chris was drawn to the South by the allure of the ocean and has never looked back—enjoying almost any activity on the water including surfing, fishing, and boating. He has a BAA from the University of North Carolina in Management Information Systems.
Miranda Moriarty
Business Operations
Coordinator
Miranda serves as Corval’s Business Operations Coordinator, with a proven track record of excellence in administrative and leadership roles across diverse industries. Her expertise spans virtual assistance, customer service management, and leadership development. At Corval, she leverages her strong background in coordination and team management to enhance operational efficiencies and support business growth. Miranda's commitment to excellence and her ability to thrive in dynamic environments make her a key asset to the Corval team.
Allison Murphy
Head of Growth
and channel sales
Allison Murphy joined Corval in 2024 as the Head of Growth and Channel Sales to lead the growth and market expansion of Corval. Allison has extensive life sciences experience and expertise in technology with depth and breadth in the enterprise and software sales environment. Her most recent executive sales positions were President of Strategic Partnerships and Consulting at POCN, an educational community dedicated to PAs and NPs, Managing Director of Life Sciences at Curate Insights, US Director of Veeva Link, and VP of Business Development Commercial Solutions at Syneos Health. Prior to these roles, she spent ten years at Lilly in customer-facing roles in sales and medical affairs. She began her professional training as a Nurse Clinician in academic centers
Allison’s previous experiences demonstrate her unique talents as a strategic thinker and compassionate leader. She has a proven track record in leading high-performing sales teams, developing effective go-to-market strategies across multiple segments, and cultivating strong relationships with key stakeholders in the biopharmaceutical sector. Allison holds a Bachelor of Nursing from Villanova University.
Johanna Power
Head of Finance
and operations
Casey Ryan
Product Manager
Casey joins Corval as a Product manager where she is responsible for building and driving the implementation of the product roadmap. Casey first joined Corval in 2020 as a business analyst, in this role she oversaw the implementation of Corval’s many data sets. She then became Junior Project Manager in 2021, further honing her skill in the product before moving into the role of Product manager in 2023. Prior to joining Corval, Casey was a Corps Support Intern at City Year Boston, where she managed events and seminars for incoming members and external partners. Casey also served as a Public Affairs Intern at Planned Parenthood of Northern New England, where she assisted in a research study in collaboration with Duke University to determine the effectiveness of deep-canvassing initiatives. Casey is a recent graduate from Hamilton College, where she earned a BA in Government and Hispanic Studies. She is also a proud alum of NOLS, where she bravely led a team expedition through the Yukon, CA wilderness.
Radhika Sabnis
Associate Director Customer & Partner Success
Radhika Sabnis joined Corval in 2022 as a Customer Coordinator where she is responsible for overseeing all project activities related to onboarding customers. She has several years of project management experience in the biopharma and healthcare domain and has led complex workstreams spanning software implementation, manufacturing, operations, and quality and process improvement. In her recent position with Healthcentric Advisors, she worked with hospital systems and clinicians throughout Massachusetts to maintain healthcare quality compliance, streamline workflows, and maximize Medicare payments. She has held similar management and consulting roles at Partners HealthCare, Exeter Health Resources, and Lonza Biologics. In addition to her PMP certification, Radhika holds an MS in Genetic Engineering from Bangalore University and an MBA from the University of New Hampshire.
Lindsay
Schandelmayer
Director
Revenue Operations
Lindsay serves as the Director of Business Operations, where she is responsible for coordinating cross-functional activities and operational logistics.
She has over 15 years of experience in executive administration and event coordination, supporting teams to streamline workflows and ensure business goals are achieved. Most recently, Lindsay was the Conference Center Manager at Berkshire Partners, where she oversaw execution of more than 800 investor events annually. Preceding that, she was a Marketing Assistant at Jefferies Financial Group, where she supported timely execution of sales and marketing campaigns. Lindsay earned her BA in communications from Keene State College.
Michelle Xie
Business Analyst Revenue Operations
Michelle Xie is a Business Analyst at Corval where she assists with market research, data analysis, documentation, and process improvement. She first joined Corval in 2022 as a Product and Platform Intern, assisting with developing feature roadmaps and defining milestones. From there, she moved into a Business Operations Intern role where she worked closely with the Director of Business Operations to coordinate operational logistics and activities on a day-to-day basis. Prior to joining Corval, she was a Marketing Intern at Living in Freedom Together.
Michelle has a BA in Management and is a recent MBA graduate with a concentration in Information Management and Business Analytics from Clark University.
We couldn't do it without the help of our product and development partners.
Join Us
We are a small and mighty team building a product at the exciting intersection of biopharma and technology.
We value our customers, our partners, and our people. We believe in a culture of learning, collaboration, empathy, and diversity. We believe that work and life should be in balance and that striving for excellence can co-exist with striving for happiness. If you are interested in helping us build this innovative company, learning a lot, and having fun while doing it, we’d love to hear from you.
Email us at careers@corval.io.
Follow us on LinkedIn.
Questions?
Schedule a conversation with our commercialization expert to understand your options.
General Inquiries:
info@corval.io
Customer Support:
support@corval.io
Corval is aligned with the Life Science Cares mission to make a meaningful impact on poverty by harnessing the resources of the life sciences industry. As a sign of our commitment, we are donating a portion of sales to Life Science Cares.